Cargando…
Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients
Mexico has been under official epidemiological alert due to diabetes since 2016. This study presents new information on the frequency and variants of metformin transporters OCT1, OCT2, OCT3, ABCB1, and CYP2C9 variants as well. It also reports the association with HbA1c control on 103 DMT2 patients....
Autores principales: | Ortega-Ayala, Adiel, Rodríguez-Rivera, Nidia Samara, de Andrés, Fernando, LLerena, Adrián, Pérez-Silva, Eliseo, Espinosa-Sánchez, Adriana Guadalupe, Molina-Guarneros, Juan Arcadio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318506/ https://www.ncbi.nlm.nih.gov/pubmed/35890074 http://dx.doi.org/10.3390/ph15070774 |
Ejemplares similares
-
Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population
por: Rodríguez-Rivera, Nidia Samara, et al.
Publicado: (2017) -
Frequency of CYP2C9 (*2, *3 and IVS8-109A>T) allelic variants, and their clinical implications, among Mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin
por: Cuautle-Rodríguez, Patricia, et al.
Publicado: (2019) -
The inefficacy of antiangiogenic therapies
por: Ribatti, Domenico
Publicado: (2010) -
Lacosamide: Inefficacy: case report
Publicado: (2021) -
Inefficacy of Antim. Tart. in the Cure of Ophthalmia
Publicado: (1814)